• Published On : Jan-2017 |
  • Pages : 182 Pages |
  • Format :

1. Executive Summary

2. Life Science Products Market Introduction
   2.1. Life Science Products Market Introduction and Definition
   2.2. Life Science Products Market Taxonomy

3. Life Science Products Market Analysis Scenario
   3.1. Market Scenario (US$ Mn) and Forecast
   3.2. Market Size (US$ Mn) and Forecast
         3.2.1. Market Size and Y-o-Y Growth
         3.2.2. Absolute $ Opportunity

4. Life Science Products Market Dynamics
   4.1. Macro-economic Factors
   4.2. Drivers
         4.2.1. Demand Side
         4.2.2. Supply Side
   4.3. Restraints
   4.4. Opportunity
   4.5. Trends

5. Global Life Science Products Market Analysis and Forecast, By Product Type
   5.1. Introduction
         5.1.1. Basis Point Share (BPS) Analysis By Product Type
         5.1.2. Y-o-Y Growth Projections By Product Type
   5.2. Market Share and Y-o-Y Analysis By Product Type
   5.3. Market Value and Absolute $ Opportunity By Product Type
         5.3.1. Recombinant Proteins
         5.3.2. Cell Lines
         5.3.3. Antibodies
         5.3.4. Viable Tumor Samples
         5.3.5. Tumor Tissue Microarrays
   5.4. Market Value Analysis and Forecast, By Product Type
         5.4.1. Recombinant Proteins
         5.4.2. Cell Lines
         5.4.3. Antibodies
         5.4.4. Viable Tumor Samples
         5.4.5. Tumor Tissue Microarrays
   5.5. Market Attractiveness Analysis, By Product Type

6. Global Life Science Products Market Analysis and Forecast, By Application
   6.1. Introduction
         6.1.1. Basis Point Share (BPS) Analysis By Application
         6.1.2. Y-o-Y Growth Projections By Application
   6.2. Market Share and Y-o-Y Analysis By Application
   6.3. Market Value and Absolute $ Opportunity By Application
         6.3.1. Drug Discovery & Development 
         6.3.2. Basic Research
         6.3.3. Toxicity Screening
         6.3.4. Biopharmaceutical Production
         6.3.5. Drug Screening
         6.3.6. Tissue Engineering
         6.3.7. Forensic Testing
   6.4. Market Value Analysis and Forecast, By Application
   6.5. Market Attractiveness Analysis, By Application

7. Global Life Science Products Market Analysis and Forecast, By End User
   7.1. Introduction
         7.1.1. Basis Point Share (BPS) Analysis By End User
         7.1.2. Y-o-Y Growth Projections By End User
   7.2. Market Share and Y-o-Y Analysis By End User
   7.3. Market Value and Absolute $ Opportunity By End User
         7.3.1. Biopharmaceutical Companies
         7.3.2. Contract Research Organizations (CROs)
         7.3.3. Academic & Research Institutes
         7.3.4. Forensic Science Laboratories
         7.3.5. Food & Beverage Companies
         7.3.6. Diagnostic Centers
         7.3.7. Others
   7.4. Market Value Analysis and Forecast, By End User
   7.5. Market Attractiveness Analysis, By End User

8. Global Life Science Products Market Analysis and Forecast, By Region
   8.1. Introduction
         8.1.1. Basis Point Share (BPS) Analysis By Region
         8.1.2. Y-o-Y Growth Projections By Region
   8.2. Market Share and Y-o-Y Analysis By Region
   8.3. Market Value and Absolute $ Opportunity By Region
         8.3.1. North America
         8.3.2. Latin America
         8.3.3. Europe
         8.3.4. Asia Pacific
         8.3.5. Middle East & Africa
   8.4. Market Value Analysis and Forecast, By Region
   8.5. Market Attractiveness Analysis, By Region

9. North America Life Science Products Market Analysis and Forecast
   9.1. Introduction
         9.1.1. Basis Point Share (BPS) Analysis By Country
         9.1.2. Y-o-Y Growth Projections By Country
   9.2. Market Value Analysis and Forecast, By Country
         9.2.1. U.S.
         9.2.2. Canada
   9.3. Market Value Analysis and Forecast, By Product Type
         9.3.1. Recombinant Proteins
         9.3.2. Cell Lines
         9.3.3. Antibodies
         9.3.4. Viable Tumor Samples
         9.3.5. Tumor Tissue Microarrays
   9.4. Market Value Analysis and Forecast, By Application
         9.4.1. Drug Discovery & Development 
         9.4.2. Basic Research
         9.4.3. Toxicity Screening
         9.4.4. Biopharmaceutical Production
         9.4.5. Drug Screening
         9.4.6. Tissue Engineering
         9.4.7. Forensic Testing
   9.5. Market Value Analysis and Forecast, By End User
         9.5.1. Biopharmaceutical Companies
         9.5.2. Contract Research Organizations (CROs)
         9.5.3. Academic & Research Institutes
         9.5.4. Forensic Science Laboratories
         9.5.5. Food & Beverage Companies
         9.5.6. Diagnostic Centers
         9.5.7. Others
   9.6. Market Attractiveness Analysis
         9.6.1. By Country
         9.6.2. By Product Type
         9.6.3. By Application
         9.6.4. By End User
10. Latin America Life Science Products Market Analysis and Forecast
   10.1. Introduction
         10.1.1. Basis Point Share (BPS) Analysis By Country
         10.1.2. Y-o-Y Growth Projections By Country
   10.2. Market Value Analysis and Forecast, By Country
         10.2.1. Brazil
         10.2.2. Mexico
         10.2.3. Argentina
         10.2.4. Rest of Latin America
   10.3. Market Value Analysis and Forecast, By Product Type
         10.3.1. Recombinant Proteins
         10.3.2. Cell Lines
         10.3.3. Antibodies
         10.3.4. Viable Tumor Samples
         10.3.5. Tumor Tissue Microarrays
   10.4. Market Value Analysis and Forecast, By Application
         10.4.1. Drug Discovery & Development 
         10.4.2. Basic Research
         10.4.3. Toxicity Screening
         10.4.4. Biopharmaceutical Production
         10.4.5. Drug Screening
         10.4.6. Tissue Engineering
         10.4.7. Forensic Testing
   10.5. Market Value Analysis and Forecast, By End User
         10.5.1. Biopharmaceutical Companies
         10.5.2. Contract Research Organizations (CROs)
         10.5.3. Academic & Research Institutes
         10.5.4. Forensic Science Laboratories
         10.5.5. Food & Beverage Companies
         10.5.6. Diagnostic Centers
         10.5.7. Others
   10.6. Market Attractiveness Analysis
         10.6.1. By Country
         10.6.2. By Product Type
         10.6.3. By Application
         10.6.4. By End User

11. Europe Life Science Products Market Analysis and Forecast
   11.1. Introduction
         11.1.1. Basis Point Share (BPS) Analysis By Country
         11.1.2. Y-o-Y Growth Projections By Country
   11.2. Market Value Analysis and Forecast, By Country
         11.2.1. U.K.
         11.2.2. France
         11.2.3. Germany
         11.2.4. Italy
         11.2.5. Spain
         11.2.6. Russia
         11.2.7. Rest of Europe
   11.3. Market Value Analysis and Forecast, By Product Type
         11.3.1. Recombinant Proteins
         11.3.2. Cell Lines
         11.3.3. Antibodies
         11.3.4. Viable Tumor Samples
         11.3.5. Tumor Tissue Microarrays
   11.4. Market Value Analysis and Forecast, By Application
         11.4.1. Drug Discovery & Development 
         11.4.2. Basic Research
         11.4.3. Toxicity Screening
         11.4.4. Biopharmaceutical Production
         11.4.5. Drug Screening
         11.4.6. Tissue Engineering
         11.4.7. Forensic Testing
   11.5. Market Value Analysis and Forecast, By End User
         11.5.1. Biopharmaceutical Companies
         11.5.2. Contract Research Organizations (CROs)
         11.5.3. Academic & Research Institutes
         11.5.4. Forensic Science Laboratories
         11.5.5. Food & Beverage Companies
         11.5.6. Diagnostic Centers
         11.5.7. Others
   11.6. Market Attractiveness Analysis
         11.6.1. By Country
         11.6.2. By Product Type
         11.6.3. By Application
         11.6.4. By End User

12. Asia Pacific Life Science Products Market Analysis and Forecast
   12.1. Introduction
         12.1.1. Basis Point Share (BPS) Analysis By Country
         12.1.2. Y-o-Y Growth Projections By Country
   12.2. Market Value Analysis and Forecast, By Country
         12.2.1. Japan
         12.2.2. China
         12.2.3. India
         12.2.4. Australia & New Zealand
         12.2.5. ASEAN
         12.2.6. Rest of Asia Pacific
   12.3. Market Value Analysis and Forecast, By Product Type
         12.3.1. Recombinant Proteins
         12.3.2. Cell Lines
         12.3.3. Antibodies
         12.3.4. Viable Tumor Samples
         12.3.5. Tumor Tissue Microarrays
   12.4. Market Value Analysis and Forecast, By Application
         12.4.1. Drug Discovery & Development 
         12.4.2. Basic Research
         12.4.3. Toxicity Screening
         12.4.4. Biopharmaceutical Production
         12.4.5. Drug Screening
         12.4.6. Tissue Engineering
         12.4.7. Forensic Testing
   12.5. Market Value Analysis and Forecast, By End User
         12.5.1. Biopharmaceutical Companies
         12.5.2. Contract Research Organizations (CROs)
         12.5.3. Academic & Research Institutes
         12.5.4. Forensic Science Laboratories
         12.5.5. Food & Beverage Companies
         12.5.6. Diagnostic Centers
         12.5.7. Others
   12.6. Market Attractiveness Analysis
         12.6.1. By Country
         12.6.2. By Product Type
         12.6.3. By Application
         12.6.4. By End User

13. Middle East & Africa Life Science Products Market Analysis and Forecast
   13.1. Introduction
         13.1.1. Basis Point Share (BPS) Analysis By Country
         13.1.2. Y-o-Y Growth Projections By Country
   13.2. Market Value Analysis and Forecast, By Country
         13.2.1. GCC Countries
         13.2.2. South Africa
         13.2.3. Rest of Middle East & Africa
   13.3. Market Value Analysis and Forecast, By Product Type
         13.3.1. Recombinant Proteins
         13.3.2. Cell Lines
         13.3.3. Antibodies
         13.3.4. Viable Tumor Samples
         13.3.5. Tumor Tissue Microarrays
   13.4. Market Value Analysis and Forecast, By Application
         13.4.1. Drug Discovery & Development 
         13.4.2. Basic Research
         13.4.3. Toxicity Screening
         13.4.4. Biopharmaceutical Production
         13.4.5. Drug Screening
         13.4.6. Tissue Engineering
         13.4.7. Forensic Testing
   13.5. Market Value Analysis and Forecast, By End User
         13.5.1. Biopharmaceutical Companies
         13.5.2. Contract Research Organizations (CROs)
         13.5.3. Academic & Research Institutes
         13.5.4. Forensic Science Laboratories
         13.5.5. Food & Beverage Companies
         13.5.6. Diagnostic Centers
         13.5.7. Others
   13.6. Market Attractiveness Analysis
         13.6.1. By Country
         13.6.2. By Product Type
         13.6.3. By Application
         13.6.4. By End User

14. Competition Landscape
   14.1. Product-Vendor Mapping Dashboard
   14.2. Company Share Analysis (2015)
   14.3. Company Profiles (Details – Overview, Key Ratios, Financials, Strategy, SWOT, Recent Developments)
   14.4. Global Players
         14.4.1. Abcam Plc
         14.4.2. A.M.S. Biotechnology (Europe) Limited
         14.4.3. Bio-Rad Laboratories Inc.
         14.4.4. BPS Bioscience Inc.
         14.4.5. Crown Bioscience Inc.
         14.4.6. Genscript Biotech Corporation
         14.4.7. Merck Millipore Limited
         14.4.8. PerkinElmer Inc.
         14.4.9. Sigma Aldrich Corp.
         14.4.10.  Thermo Fisher Scientific Inc.

15. Assumptions and Acronyms Used

16. Research Methodology


List of Tables

Table 01: Global Life Science Products Market Value (US$ Mn) Analysis and Forecast By Product Type, 2015–2024
Table 02: Global Life Science Products Market Value (US$ Mn) Analysis and Forecast By Recombinant Proteins Segment Type, 2015–2024
Table 03: Global Life Science Products Market Value (US$ Mn) Analysis and Forecast By Cell Lines Segment Type, 2015–2024
Table 04: Global Life Science Products Market Value (US$ Mn) Analysis and Forecast By Antibodies Segment Type, 2015–2024
Table 05: Global Life Science Products Market Value (US$ Mn) Analysis and Forecast By Application, 2015–2024
Table 06: Global Life Science Products Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2024
Table 07: Global Life Science Products Market Value (US$ Mn) Analysis and Forecast By Region, 2015–2024
Table 08: North America Life Science Products Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 09: North America Life Science Products Market Value (US$ Mn) Analysis and Forecast By Product Type, 2015–2024
Table 10: North America Life Science Products Market Value (US$ Mn) Analysis and Forecast By Recombinant Proteins Segment Type, 2015–2024
Table 11: North America Life Science Products Market Value (US$ Mn) Analysis and Forecast By Cell Lines Segment Type, 2015–2024
Table 12: North America Life Science Products Market Value (US$ Mn) Analysis and Forecast By Antibodies Segment Type, 2015–2024
Table 13: North America Life Science Products Market Value (US$ Mn) Analysis and Forecast By Application, 2015–2024
Table 14: North America Life Science Products Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2024
Table 15: Latin America Life Science Products Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 16: Latin America Life Science Products Market Value (US$ Mn) Analysis and Forecast By Product Type, 2015–2024
Table 17: Latin America Life Science Products Market Value (US$ Mn) Analysis and Forecast By Recombinant Proteins Segment Type, 2015–2024
Table 18: Latin America Life Science Products Market Value (US$ Mn) Analysis and Forecast By Cell Lines Segment Type, 2015–2024
Table 19: Latin America Life Science Products Market Value (US$ Mn) Analysis and Forecast By Antibodies Segment Type, 2015–2024
Table 20: Latin America Life Science Products Market Value (US$ Mn) Analysis and Forecast By Application, 2015–2024
Table 21: Latin America Life Science Products Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2024
Table 22: Europe Life Science Products Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 23: Europe Life Science Products Market Value (US$ Mn) Analysis and Forecast By Product Type, 2015–2024
Table 24: Europe Life Science Products Market Value (US$ Mn) Analysis and Forecast By Recombinant Proteins Segment Type, 2015–2024
Table 25: Europe Life Science Products Market Value (US$ Mn) Analysis and Forecast By Cell Lines Segment Type, 2015–2024
Table 26: Europe Life Science Products Market Value (US$ Mn) Analysis and Forecast By Antibodies Segment Type, 2015–2024
Table 27: Europe Life Science Products Market Value (US$ Mn) Analysis and Forecast By Application, 2015–2024
Table 28: Europe Life Science Products Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2024
Table 29: Asia-Pacific Life Science Products Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 30: Asia-Pacific Life Science Products Market Value (US$ Mn) Analysis and Forecast By Product Type, 2015–2024
Table 31: Asia-Pacific Life Science Products Market Value (US$ Mn) Analysis and Forecast By Recombinant Proteins Segment Type, 2015–2024
Table 32: Asia-Pacific Life Science Products Market Value (US$ Mn) Analysis and Forecast By Cell Lines Segment Type, 2015–2024
Table 33: Asia-Pacific Life Science Products Market Value (US$ Mn) Analysis and Forecast By Antibodies Segment Type, 2015–2024
Table 34: Asia-Pacific Life Science Products Market Value (US$ Mn) Analysis and Forecast By Application, 2015–2024
Table 35: Asia-Pacific Life Science Products Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2024
Table 36: MEA Life Science Products Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 37: MEA Life Science Products Market Value (US$ Mn) Analysis and Forecast By Product Type, 2015–2024
Table 38: MEA Life Science Products Market Value (US$ Mn) Analysis and Forecast By Recombinant Proteins Segment Type, 2015–2024
Table 39: MEA Life Science Products Market Value (US$ Mn) Analysis and Forecast By Cell Lines Segment Type, 2015–2024
Table 40: MEA Life Science Products Market Value (US$ Mn) Analysis and Forecast By Antibodies Segment Type, 2015–2024
Table 41: MEA Life Science Products Market Value (US$ Mn) Analysis and Forecast By Application, 2015–2024
Table 42: MEA Life Science Products Market Value (US$ Mn) Analysis and Forecast By End User, 2015–2024


List of Figures

Figure 01: Global Life Science Products Market – Scenario Forecast, 2015–2024 (US$ Mn)
Figure 02: Global Life Science Products Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 03: Global Life Science Products Market Absolute $ Opportunity, 2016–2024
Figure 04: Global Life Science Products Market Share and BPS Analysis (%) By Product Type, 2016 & 2024
Figure 05: Global Life Science Products Market Y-o-Y growth (%) By Product Type, 2016–2024
Figure 06: Global Life Science Products Market Share and BPS Analysis (%) By Recombinant Proteins, 2016 & 2024
Figure 07: Global Life Science Products Market Y-o-Y growth (%) By Recombinant Proteins, 2016–2024
Figure 08: Global Life Science Products Market Share and BPS Analysis (%) By Cell Lines, 2016 & 2024
Figure 09: Global Life Science Products Market Y-o-Y growth (%) By Cell Lines, 2016–2024
Figure 10: Global Life Science Products Market Share and BPS Analysis (%) By Antibodies, 2016 & 2024
Figure 11: Global Life Science Products Market Y-o-Y growth (%) By Antibodies, 2016–2024
Figure 12: Global Life Science Products Market Absolute $ Opportunity By Recombinant Proteins Segment,
Figure 13: Global Life Science Products Market Absolute $ Opportunity By Cell Lines Segment, 2016–2024
Figure 14: Global Life Science Products Market Absolute $ Opportunity By Antibodies Segment, 2016–2024
Figure 15: Global Life Science Products Market Absolute $ Opportunity By Viable Tumor Samples Segment, 2016–2024
Figure 16: Global Life Science Products Market Absolute $ Opportunity By Tumor Tissue Microarrays Segment, 2016–2024
Figure 17: Global Life Science Products Market Attractiveness Analysis By Product Type, 2016–2024
Figure 18: Global Life Science Products Market Attractiveness Analysis By Recombinant Proteins Segment, 2016–2024
Figure 19: Global Life Science Products Market Attractiveness Analysis By Cell Lines Segment, 2016–2024
Figure 20: Global Life Science Products Market Attractiveness Analysis By Antibodies Segment, 2016–2024
Figure 21: Global Life Science Products Market Share and BPS Analysis (%) By Application, 2016 & 2024
Figure 22: Global Life Science Products Market Y-o-Y growth (%) By Application, 2016–2024
Figure 23: Global Life Science Products Market Absolute $ Opportunity By Drug Discovery & Development Segment, 2016–2024
Figure 24: Global Life Science Products Market Absolute $ Opportunity By Basic Research Segment, 2016–2024
Figure 25: Global Life Science Products Market Absolute $ Opportunity By Toxicity Screening Segment, 2016–2024
Figure 26: Global Life Science Products Market Absolute $ Opportunity By Biopharmaceutical Production Segment, 2016–2024
Figure 27: Global Life Science Products Market Absolute $ Opportunity By Drug Screening Segment, 2016–2024
Figure 28: Global Life Science Products Market Absolute $ Opportunity By Tissue Engineering Segment, 2016–2024
Figure 29: Global Life Science Products Market Absolute $ Opportunity By Forensic Testing Segment, 2016–2024
Figure 30: Global Life Science Products Market Attractiveness Analysis By Application, 2016–2024
Figure 31: Global Life Science Products Market Share and BPS Analysis (%) By End User, 2016 & 2024
Figure 32: Global Life Science Products Market Y-o-Y growth (%) By End User, 2016–2024
Figure 33: Global Life Science Products Market Absolute $ Opportunity By Biopharmaceutical Companies Segment,
Figure 34: Global Life Science Products Market Absolute $ Opportunity By Contract Research Organizations (CROs) Segment, 2016–2024
Figure 35: Global Life Science Products Market Absolute $ Opportunity By Academic & Research Institutes Segment,
Figure 36: Global Life Science Products Market Absolute $ Opportunity By Forensic Science Laboratories Segment, 2016–2024
Figure 37: Global Life Science Products Market Absolute $ Opportunity By Food & Beverage Companies Segment,
Figure 38: Global Life Science Products Market Absolute $ Opportunity By Diagnostic Centers Segment, 2016–2024
Figure 39: Global Life Science Products Market Absolute $ Opportunity By Others Segment, 2016–2024
Figure 40: Global Life Science Products Market Attractiveness Analysis By End User, 2016–2024
Figure 41: Global Life Science Products Market Value (US$ Mn) and CAGR (%) By Region, 2015, 2020, and 2024
Figure 42: Global Life Science Products Market Share and BPS Analysis (%) By Region, 2016 & 2024
Figure 43: Global Life Science Products Market Y-o-Y growth (%) By Region, 2016–2024
Figure 44: North America Life Science Products Market Absolute $ Opportunity, 2016–2024
Figure 45: Latin America Life Science Products Market Absolute $ Opportunity, 2016–2024
Figure 46: Europe Life Science Products Market Absolute $ Opportunity, 2016–2024
Figure 47: Asia-Pacific Life Science Products Market Absolute $ Opportunity, 2016–2024
Figure 48: Middle East and Africa Life Science Products Market Absolute $ Opportunity, 2016–2024
Figure 49: Global Life Science Products Market Attractiveness Analysis By Region, 2016–2024
Figure 50: North America Life Science Products Market Share Analysis (%) By Country, 2016 & 2024
Figure 51: North America Life Science Products Market Attractiveness Analysis By Country, 2016–2024
Figure 52: North America Life Science Products Market Y-o-Y growth (%) By Country, 2016–2024
Figure 53: North America Life Science Products Market Attractiveness Analysis By Product Type, 2016–2024
Figure 54: North America Life Science Products Market Attractiveness Analysis By Application, 2016–2024
Figure 55: North America Life Science Products Market Attractiveness Analysis By End User, 2016–2024
Figure 56: Latin America Life Science Products Market Share Analysis (%) By Country, 2016 & 2024
Figure 57: Latin America Life Science Products Market Attractiveness Analysis By Country, 2016–2024
Figure 58: Latin America Life Science Products Market Y-o-Y growth (%) By Country, 2016–2024
Figure 59: Latin America Life Science Products Market Attractiveness Analysis By Product Type, 2016–2024
Figure 60: Latin America Life Science Products Market Attractiveness Analysis By Application, 2016–2024
Figure 61: Latin America Life Science Products Market Attractiveness Analysis By End User, 2016–2024
Figure 62: Europe Life Science Products Market Share Analysis (%) By Country, 2016 & 2024
Figure 63: Europe Life Science Products Market Attractiveness Analysis By Country, 2016–2024
Figure 64: Europe Life Science Products Market Y-o-Y growth (%) By Country, 2016–2024
Figure 65: Europe Life Science Products Market Attractiveness Analysis By Product Type, 2016–2024
Figure 66: Europe Life Science Products Market Attractiveness Analysis By Application, 2016–2024
Figure 67: Europe Life Science Products Market Attractiveness Analysis By End User, 2016–2024
Figure 68: Asia-Pacific Life Science Products Market Share Analysis (%) By Country, 2016 & 2024
Figure 69: Asia-Pacific Life Science Products Market Attractiveness Analysis By Country, 2016–2024
Figure 70: Asia-Pacific Life Science Products Market Y-o-Y growth (%) By Country, 2016–2024
Figure 71: Asia-Pacific Life Science Products Market Attractiveness Analysis By Product Type, 2016–2024
Figure 72: Asia-Pacific Life Science Products Market Attractiveness Analysis By Application, 2016–2024
Figure 73: Asia-Pacific Life Science Products Market Attractiveness Analysis By End User, 2016–2024
Figure 74: MEA Life Science Products Market Share Analysis (%) By Country, 2016 & 2024
Figure 75: MEA Life Science Products Market Attractiveness Analysis By Country, 2016–2024
Figure 76: MEA Life Science Products Market Y-o-Y growth (%) By Country, 2016–2024
Figure 77: MEA Life Science Products Market Attractiveness Analysis By Product Type, 2016–2024
Figure 78: MEA Life Science Products Market Attractiveness Analysis By Application, 2016–2024
Figure 79: MEA Life Science Products Market Attractiveness Analysis By End User, 2016–2024
Figure 80: Global Life Science Products Company Market Share Analysis, 2015